LATEST UPDATES » Big Data, Bigger Disease Management and Current preparations to manage the Future Health of Singaporeans       » Big Data in Clinical Research Sector       » Professor Yuk-ling Yung receives Gerard P. Kuiper Prize       » AXA Assistance on Regenerative Medicine       » Singtel – Singapore Cancer Society Race against Cancer 2015       » Jardiance® is the only diabetes medication to show a significant reduction in both cardiovascular risk and cardiovascular death      
FEI unveils broad correlative microscopy solution set for cell biologists
FEI has announced a suite of solutions for correlative light and electron microscopy (CLEM). New methods in correlative microscopy from FEI bring data from different imaging techniques together automatically in minutes, giving cell biologists the precise information they need, when they need it. Scientists believe that correlating information from the cellular down to the molecular level will lead to breakthrough discoveries that improve their understanding and treatment of diseases, such as cancer, AIDS, and Parkinson's.

“Light microscopy encompasses a broad and varied set of techniques and methodologies, each with its own requirements for correlation. One workflow does not fit all,” said Dominique Hubert, Vice President and General Manager of FEI's Life Sciences Business Unit. “We have developed a set of workflows that are flexible enough to cover a significant share of the possible applications. And we are committed to extending that coverage as the science develops.”

Electron microscopy (EM) offers extremely high image resolution—1,000 or more times better than light microscopes. Light microscopes (LM) offer a wide variety of specialized techniques, such as fluorescent labeling, that can identify a single molecule or structure within a large, complex environment like the interior of a living cell. Correlating between the two techniques allows scientists to use LM to find the target and EM to explore its form and function. Correlative microscopy allows investigators to find a feature of interest faster in the EM, gain additional information about its structure down to the molecular scale, and understand relationships between the feature and its larger scale context.

 Oregon Health and Science University's Professor Joe Gray, who is based in Portland, Oregon, said: “Biologists want to understand the molecular events and interactions that constitute the larger scale processes we observe in cells and tissues. This will require integration of information from multiple resolution scales, for example, ultrastructural analysis of cells that reside in specific microenvironmental niches. The iCorr system allows us to quickly find fluorescently stained cells of interest using fluorescence microscopy and followed by detailed structural analysis using electron microscopy.”

Roger Wepf, Director of electron microscopy at the Swiss Federal Institute of Technology in Zurich adds, “With CorrSight, sample preparation for the electron microscope is integrated with the light microscope, using on-board fixation. We identify the target structure and prepare the sample on the CorrSight light microscope platform, then transfer the sample to the electron microscope and, with a few clicks of the mouse, navigate directly the target. This is exactly what we have been missing since it allows us to reduce manual, tedious work and improve reproducibility. CorrSight and MAPS will open new applications in correlative microscopy that were not possible before.”

Hubert added, “At this point, we have only glimpsed the potential of correlative microscopy. It promises to open whole new avenues of investigation into the relationships between structure and function in biological systems at the finest scale. FEI is committed to leading the expansion of this applications space by developing correlative workflow solutions for the broadest range of techniques and methodologies.”

Click here for the complete issue.

news A Heroic Voyage — Sydney Brenner's Life in Science
news VeloX, A Minimally Invasive Prosthetic Heart Valve for treating Mitral Regurgitation
news Anti-CD25 monoclonal antibody (90Y-daclizumab) a favorable target towards systemic radio-immunotherapy in Hodgkin's Lymphoma

Credits to Sony Computer Entertainment and click here for behind the scenes.

APBN Editorial Calendar 2015
Trends and Predictions for 2015 Robotics in Healthcare Nutrition Universal Health Coverage
Start-Up Biotech Companies Preventative and Translational Medicine Biofuels ASEAN Economic Community and Asia's Life Sciences Industry
Big Data: Healthcare and Drug Development Antibody Engineering in Japan Christmas Edition
APBN Editorial Calendar 2016
Korea's Biotechnology Industry Nutrition and Allergies: Are we, Too Clean? Medical Devices and Technology: Innovation that leaves an Inspiration Tobacco Smoking: The 'Real' Cost of One Cigarette
Life-Saving Opportunities: A Guide to Regenerative Medicine Occupational Health Water Technology Olympics: Evolution of Sports
Respiratory: Seasonal flu viruses
About Us
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» Editorial Enquiries: biotech_edit@wspc.com
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   Ms PoPo Kwok or Ms Sok Ching Lim
Copyright© 2015 World Scientific Publishing Co Pte Ltd  •  Privacy Policy